Today, Enhanced Group - the parent company of the @enhanced_games and the “Live Enhanced” telehealth platform - begins trading on the New York Stock Exchange under the ticker $ENHA after its successful merger with "A Paradise SPAC".
I believe Enhanced Group has the potential to become a generation-defining company - one that reshapes how we think about sport, health, and human performance, with impact far beyond its core business.
Enhanced Group combines a global sports franchise with a next-generation consumer health platform in a way the market has never seen before.
Additionally, Enhanced Group is right now conducting the largest clinical study ever undertaken to explore the effects of medical performance-enhancing drugs in unprecedented detail. I can already tell you: the findings will be fascinating and are likely to shatter many long-held myths and “urban legends”. And will potentially allow the company to create valuable intellectual property.
Read my blog post to learn more about the vision and opportunity behind the company.
And follow @enhanced_games and me for updates - the next two weeks should be full of exciting developments as we put the final touches on the Games.
Most importantly: tune in on May 24 at 5pm PST. On all major platforms.
After that night, the world of sports may never look the same again.
elotrade challenges include:
• 1-step and 2-step options
• Clear rules
• Crypto native trading
• Accounts up to $200k
First 2,000 traders get early access.
https://t.co/omYnztE2vU
Nicely written.
I own a ton of shares, i am not in a rush, i was a bit surprised by the movement yesterday but ultimately grateful as i grabbed shares at a discount vs. pre-approval level.
Analysts see 7-8 dollars, for a derisked drug that bolts in a couple of big pharma, a couple of weeks away from the JPM Conference, now trading at $2.3.
Xmas came early.
$MIST $XBI
$MIST $XBI the number of bots throwing b/s at $MIST makes me think someone is short and afraid of what will inevitably happen:
- 3 analysts have raised their target price ($8 per share),
- the drug is derisked,
- funding coming in from RTW on their royalty deal,
- and the way is paved to tackle Atrial Fibrillation...
The 4 handle is around the corner and those shorts won't have much money left to pay fake bots!
Can't wait.
$XBI $MIST finally halted for the right reason: FDA Approval! 🎉
The setup:
1️⃣ PSVT: Approved - stock to $5+ just on this, and let's see what happens on the squeeze
2️⃣ AFib: Phase 3 ready "hidden gem." - market is HUGE and it makes it a nice target for the big players - stock upside here
3️⃣ Cash: Secured - equity deal last summer AND the $75mm RTW deal coming in - strong negotiating power... even further stock upside
With #JPM26 weeks away, MIST is the perfect "bolt-on" target for names like Novartis ( $NVS ), BMS ( $BMY ), or Pfizer ( $PFE ).
Expect a massive move vs. Friday, obviously.
This is a fundamental game changer that likely justifies trading considerably higher. 🚀 I am going in heavy handed
(not financial advice, full disclosure I own and have buy orders in for >300k shares...)
@Ssunten_ $MIST $XBI planing to buy in premarket all the way up to $5 if i find any sellers that is… and then we let the SQUEEZE take care of them heathens. Including the bald nurse.
@meremrtl@NicholasChoupak Stephen admit it: i read your tweets, and it’s quite clear you’re sour grapes (flat) or ate the SSS (shit sandwich short). No need to continue to be a pain, move on to your next short and let us enjoy our well deserved rally to the moon. 😘
@RyanSTTrader Not sure you write this b/s to try to push the price down and load up, or you are just short and try to save your a$$ with these silly messages. The company has a strong drug, why you keep talking nonsense? You wanna get it cheap? Or just unresolved childhood trauma popping up?